Market capitalization | $1.42b |
Enterprise Value | $2.13b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 19.46 |
EV/Sales (TTM) EV/Sales | 0.87 |
P/S ratio (TTM) P/S ratio | 0.58 |
P/B ratio (TTM) P/B ratio | 1.35 |
Revenue growth (TTM) Revenue growth | 37.65% |
Revenue (TTM) Revenue | $2.46b |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
17 Analysts have issued a Evolent Health Inc Class A forecast:
17 Analysts have issued a Evolent Health Inc Class A forecast:
Sep '24 |
+/-
%
|
||
Revenue | 2,464 2,464 |
38%
38%
|
|
Gross Profit | 274 274 |
16%
16%
|
|
EBITDA | 131 131 |
13%
13%
|
EBIT (Operating Income) EBIT | 11 11 |
44%
44%
|
Net Profit | -72 -72 |
21%
21%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. It operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
Head office | United States |
CEO | Seth Blackley |
Employees | 4,700 |
Founded | 2011 |
Website | www.evolent.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.